Three Synchronous Malignancy in a Patient with Psoriasis Treated with Antitumor Necrosis Factor-Alpha: A Case Report and Review of Literature

Abstract

Anti-tumor necrosis factor-α (anti-TNF) agents are used to treat different autoimmune conditions. Etanercept and Adalimumab are examples of this class of medications used for the treatment of Psoriasis. The Food and Drug Administration (FDA) released a review in 2003 of clinical trials using anti-TNF agents and reported a relative risk (RR) for lymphoma… (More)

Topics

4 Figures and Tables